Free
Perioperative Medicine  |   November 2014
Effects of Sevoflurane and Propofol on Frontal Electroencephalogram Power and Coherence
Author Notes
  • From the Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts (O.A., K.J.P., A.L.S., K.E.H., E.N.B., P.L.P.); Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts (M.B.W.); Harvard Medical School, Boston, Massachusetts (O.A., E.N.B., P.L.P.); Department of Brain and Cognitive Science, Massachusetts Institute of Technology, Cambridge, Massachusetts (M.B.W., E.N.B., P.L.P.); Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts (E.N.B.); and Institute for Medical Engineering and Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts (E.N.B.).
  • Submitted for publication April 8, 2014. Accepted for publication July 11, 2014.
    Submitted for publication April 8, 2014. Accepted for publication July 11, 2014.×
  • Address correspondence to Dr. Purdon: Massachusetts General Hospital, 149 13th Street, Rm 4005, Charlestown, Massachusetts 02129. patrickp@nmr.mgh.harvard.edu. Information on purchasing reprints may be found at www.anesthesiology.org or on the masthead page at the beginning of this issue. Anesthesiology’s articles are made freely accessible to all readers, for personal use only, 6 months from the cover date of the issue.
Article Information
Perioperative Medicine / Clinical Science / Central and Peripheral Nervous Systems / Pharmacology
Perioperative Medicine   |   November 2014
Effects of Sevoflurane and Propofol on Frontal Electroencephalogram Power and Coherence
Anesthesiology 11 2014, Vol.121, 990-998. doi:10.1097/ALN.0000000000000436
Anesthesiology 11 2014, Vol.121, 990-998. doi:10.1097/ALN.0000000000000436
Abstract

Background:: The neural mechanisms of anesthetic vapors have not been studied in depth. However, modeling and experimental studies on the intravenous anesthetic propofol indicate that potentiation of γ-aminobutyric acid receptors leads to a state of thalamocortical synchrony, observed as coherent frontal alpha oscillations, associated with unconsciousness. Sevoflurane, an ether derivative, also potentiates γ-aminobutyric acid receptors. However, in humans, sevoflurane-induced coherent frontal alpha oscillations have not been well detailed.

Methods:: To study the electroencephalogram dynamics induced by sevoflurane, the authors identified age- and sex-matched patients in which sevoflurane (n = 30) or propofol (n = 30) was used as the sole agent for maintenance of general anesthesia during routine surgery. The authors compared the electroencephalogram signatures of sevoflurane with that of propofol using time-varying spectral and coherence methods.

Results:: Sevoflurane general anesthesia is characterized by alpha oscillations with maximum power and coherence at approximately 10 Hz, (mean ± SD; peak power, 4.3 ± 3.5 dB; peak coherence, 0.73 ± 0.1). These alpha oscillations are similar to those observed during propofol general anesthesia, which also has maximum power and coherence at approximately 10 Hz (peak power, 2.1 ± 4.3 dB; peak coherence, 0.71 ± 0.1). However, sevoflurane also exhibited a distinct theta coherence signature (peak frequency, 4.9 ± 0.6 Hz; peak coherence, 0.58 ± 0.1). Slow oscillations were observed in both cases, with no significant difference in power or coherence.

Conclusions:: The study results indicate that sevoflurane, like propofol, induces coherent frontal alpha oscillations and slow oscillations in humans to sustain the anesthesia-induced unconscious state. These results suggest a shared molecular and systems-level mechanism for the unconscious state induced by these drugs.

What We Already Know about This Topic
  • Administration of propofol, a sedative hypnotic that potentiates γ-aminobutyric acid type A receptors, leads to synchronization of thalamus and cortex that is characterized by coherent frontal alpha oscillations upon loss of consciousness.

  • Whether administration of sevoflurane, which also potentiates γ-aminobutyric acid type A receptors, produces similar electroencephalogram changes is not known.

  • In humans who were administered either propofol or sevoflurane only, electroencephalogram dynamics were quantitatively evaluated.

What This Article Tells Us That Is New
  • Both propofol and sevoflurane anesthesia were characterized by alpha oscillations with coherence at 10 Hz and slow oscillations at less than 1 Hz, suggesting a common systems-level mechanism of unconsciousness.

  • Unlike propofol, sevoflurane was associated with increased power and coherence in the theta range. Whether this electroencephalogram pattern is unique to sevoflurane anesthesia remains to be determined.

SEVOFLURANE is an anesthetic agent with a rapid induction, emergence, and recovery profile.1  Evidence suggests that sevoflurane, similar to other ether derivatives in clinical use, exerts its physiological and behavioral effects by binding at multiple targets in the brain and spinal cord.2  Action at these targets includes potentiation of γ-aminobutyric acid (GABAA), glycine, and two-pore potassium channels; and inhibition of voltage-gated potassium, N-methyl-d-aspartate, muscarinic and nicotinic acetylcholine, serotonin, and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid channels.2–5  Despite the detailed characterizations of the molecular and cellular pharmacology of anesthetics, the neural circuit-level mechanisms of general anesthesia–induced unconsciousness are still being actively investigated.3,4  Extensive work has helped propose neural circuit mechanisms to the electroencephalogram patterns of propofol (2,6-di-isopropylphenol).6–12  Clinically, we have observed that sevoflurane induces stereotypical changes in the electroencephalogram that appear grossly similar to propofol (fig. 1, A–C). Hence, comparing the electroencephalogram dynamics induced by sevoflurane with that of propofol may provide insights into the neural circuit mechanism through which sevoflurane and other ether derivatives induce unconsciousness.
Fig. 1.
Representative individual spectrogram and the time domain electroencephalogram data obtained during sevoflurane general anesthesia (GA), and propofol GA. (A) Spectrogram of a patient who received sevoflurane GA. (B) Spectrogram of a patient who received propofol GA. The spectrogram displays the frequency content of signals as they change over time. Frequency is plotted on the y-axis, time is plotted on the x-axis, and the energy or power in the signal is indicated in color. Both spectrograms show power in the slow and alpha frequency bands. However, sevoflurane GA is further characterized by increased power in the theta and beta frequency bands. (C) Representative 10-s electroencephalogram traces of sevoflurane GA. (D) Representative 10-s electroencephalogram traces of propofol GA illustrating the gross similarities in electroencephalogram signal amplitudes in C. (EL) Bandpass-filtered electroencephalogram signals from the raw tracings to more clearly illustrate gross similarities in the electroencephalogram.
Image Not Available
Fig. 1.
Representative individual spectrogram and the time domain electroencephalogram data obtained during sevoflurane general anesthesia (GA), and propofol GA. (A) Spectrogram of a patient who received sevoflurane GA. (B) Spectrogram of a patient who received propofol GA. The spectrogram displays the frequency content of signals as they change over time. Frequency is plotted on the y-axis, time is plotted on the x-axis, and the energy or power in the signal is indicated in color. Both spectrograms show power in the slow and alpha frequency bands. However, sevoflurane GA is further characterized by increased power in the theta and beta frequency bands. (C) Representative 10-s electroencephalogram traces of sevoflurane GA. (D) Representative 10-s electroencephalogram traces of propofol GA illustrating the gross similarities in electroencephalogram signal amplitudes in C. (EL) Bandpass-filtered electroencephalogram signals from the raw tracings to more clearly illustrate gross similarities in the electroencephalogram.
×
Propofol primarily acts at GABAA receptors throughout the brain and spinal cord to enhance inhibition.3–5,13,14 It also potentiates glycine receptors and provides inhibition to voltage-gated potassium, acetylcholine, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic, and kainate channels among others.3–5  Unconsciousness under propofol is characterized in the electroencephalogram by alpha (8 to 12 Hz) oscillations that are coherent across the frontal cortex, delta (1 to 4 Hz) oscillations, and high-amplitude incoherent slow (0.1 to 1 Hz) oscillations.7,9,11,13,15–17  Intracortical recordings during propofol-induced unconsciousness suggest that local and long-range cortical communication are impeded by spatially incoherent slow oscillations that exhibit phase-limited spiking.15 
Analysis of the scalp electroencephalogram, a readily accessible measure of the average activity in large populations of cortical neurons, has established that propofol induces synchronous frontal alpha oscillations.7,9–11  Biophysical modeling provides further evidence that propofol induces coherent alpha activity by increasing GABAA conductance and decay time.6,12  This increase in GABAA conductance facilitates the involvement of the thalamus in a highly coherent thalamocortical alpha oscillation loop.6,12  This coherent frontal alpha oscillation pattern reduces the dimensionality of the thalamocortical network, reducing the ability of the thalamus to project and coordinate exogenous inputs to the neocortex.12–14 
Coherent alpha oscillations have also been identified in animal studies of the inhaled anesthetics during unconsciousness.18–20  However, human studies examining inhaled anesthesia-induced electroencephalogram dynamics are limited. Given that both sevoflurane and propofol are known to act at GABAA receptors,3–5,13,14 it is possible that comparing the electroencephalogram patterns elicited by sevoflurane to those elicited by propofol can provide insights into the neural circuit mechanisms of sevoflurane. Given a similar GABAergic mechanism of action, we hypothesized that the spectral and coherence features of sevoflurane general anesthesia would be similar to that of propofol general anesthesia. That is, at surgical anesthetic depth, there would be a predominance of large amplitude slow, delta, and coherent alpha oscillations.
To explore these hypotheses, we performed an observational study to record intraoperative frontal electroencephalogram in 30 patients undergoing general anesthesia with sevoflurane or propofol as the primary maintenance agent. We compared electroencephalogram dynamics during sevoflurane and propofol general anesthesia using time-varying spectral and coherence methods.
Materials and Methods
Patient Selection and Data Collection
Following a protocol approved by the Partners Human Research Committee, we reviewed our database of anesthesia and electroencephalogram recordings and identified age- and sex-matched patients in which sevoflurane (n = 30) or propofol (n = 30) was used as the sole hypnotic agent for maintenance of general anesthesia during routine surgery. Table 1 summarizes the patient characteristics, whereas table 2 summarizes the end-tidal sevoflurane vapor concentration and propofol infusion rates used during the maintenance phases of the electroencephalogram epochs selected. Table 3 provides additional information on coadministered medications.
Table 1.
Characteristics of Patients Studied
Characteristics of Patients Studied×
Image Not Available
Table 1.
Characteristics of Patients Studied
Characteristics of Patients Studied×
×
Table 2.
General Anesthesia Induction and Maintenance Agents
General Anesthesia Induction and Maintenance Agents×
Image Not Available
Table 2.
General Anesthesia Induction and Maintenance Agents
General Anesthesia Induction and Maintenance Agents×
×
Table 3.
Adjunct Medications Administered*
Adjunct Medications Administered*×
Image Not Available
Table 3.
Adjunct Medications Administered*
Adjunct Medications Administered*×
×
Frontal electroencephalogram data were recorded using the Sedline brain function monitor (Masimo Corporation, Irvine, CA). The electroencephalogram data were recorded with a preamplifier bandwidth of 0.5 to 92 Hz, sampling rate of 250 Hz, with 16-bit, 29 nV resolution. The standard Sedline Sedtrace electrode array records from electrodes located approximately at positions Fp1, Fp2, F7, and F8, with ground electrode at Fpz, and reference electrode approximately 1 cm above Fpz. Electrode impedance was less than 5 kΩ in each channel. An investigator experienced in reading the electroencephalogram (O.A.) visually inspected the data from each patient and selected electroencephalogram data free of noise and artifacts for analysis.
Electroencephalogram data segments were selected using information from the electronic anesthesia record. For each patient, 5-min electroencephalogram segments representing the maintenance phase of general anesthesia during surgery were carefully selected. The data were selected from a time period after the initial induction bolus of an intravenous hypnotic and while the maintenance agent was stable. These data have not been reported upon in previous publications.
Spectral Analysis
The power spectral density, also referred to as the power spectrum or spectrum, quantifies the frequency distribution of energy or power within a signal. For example, figure 1, A–B, shows representative electroencephalogram spectrograms under general anesthesia maintained with sevoflurane and propofol. In these spectrograms, frequencies are arranged along the y-axis, and time is along the x-axis, and power is indicated by color on a decibel (dB) scale. Figure 1, C–D, shows selected 10-s epochs of raw encephalogram signals from time-points encompassed in figure 1, A–B. Figure 1, E–L, shows the 0.1 to 1 Hz, 1 to 4 Hz, 4 to 8 Hz, and 8 to 14 Hz bandpass-filtered electroencephalogram signals from figure 1, C–D. We computed spectrograms using the multitaper method, implemented in the Chronux toolbox.21  We computed group-level spectrograms by taking the median across all patients. We also calculated the spectrum for the selected electroencephalogram epochs. The resulting power spectra were then averaged for all epochs, and 95% CIs were computed via multitaper-based jackknife techniques.21  The spectral analysis parameters were as follows: window length T = 2 s with 0 s overlap, time-bandwidth product TW = 3, number of tapers K = 5, and spectral resolution of 3 Hz. We estimated the peak power, and its frequency, of the frontal alpha oscillation for each individual subject. We then averaged across subjects to obtain the group-level peak power and frequency for these oscillations.
Coherence Analysis
The coherence quantifies the degree of correlation between two signals at a given frequency. It is equivalent to a correlation coefficient indexed by frequency: a coherence of 1 indicates that two signals are perfectly correlated at that frequency, whereas a coherence of 0 indicates that the two signals are uncorrelated at that frequency. The coherence Cxy(f) function between two signals x and y is defined as:
Display Formula
where Sxy(f) is the cross-spectrum between the signals x (t) and y (t), Sxx(f) is the power spectrum of the signal x (t), and Syy(f) is the power spectrum of the signal y (t). Similar to the spectrum and spectrogram, the coherence can be estimated as time-varying quantity called the coherogram. To obtain estimates of coherence, we computed coherograms between two frontal electroencephalogram electrodes F7 and F8 (fig. 2A) using the multitaper method, implemented in the Chronux toolbox.21  To illustrate how the coherogram quantifies relationships between signals, and how this is distinct from the spectrogram, we devised a simulated data example. Figure 2B shows the time domain traces from three simulated oscillatory signals, two of which are highly correlated (signal A and signal B), and one which is uncorrelated with the other two (signal C). Figure 2, C–E, shows the spectrograms for these signals. Figure 2, F and G, shows the coherograms for signal pairs A–B and B–C. All three signals have almost identical spectrograms, by construction, but the coherence between the signals is very different, reflecting the presence or absence of the visible correlation evident in the time domain traces. The coherogram also indicates the frequencies over which two signals are correlated. In the example in figure 2F, signals A and B are correlated at frequencies below approximately 20 Hz. This example shows how the coherogram characterizes the correlation between the two signals as a function of frequency. The coherence can be interpreted similarly.
Fig. 2.
Illustration of electroencephalogram channels, and coherence measurement. (A) Visual representation of channel locations and the two bipolar frontal channels, F7 and F8, which we used for coherence analysis. Areas in red are purely illustrative for the explanation of coherence. The bipolar frontal channels overlaying these regions may not record signals solely from the underlying cortex. (B) Simulated signals to illustrate interpretation of coherence. Signal “A” and signal “B” appear highly correlated in time, whereas signal “C” appears uncorrelated with both signals A and B. (CE) Spectrogram for simulated signals in B. The spectrogram plots signal power or energy as a function of time and frequency. Signals A, B, and C produce almost identical spectrograms; however, their coherograms will reflect differences in functional connectivity that may otherwise be overlooked. (F and G) The coherence indicates the correlation coefficient between two signals as a function of frequency (0 for no correlation, with a maximum value of 1 for perfect correlation). The coherogram plots the coherence as function of time, much like the spectrogram. This example shows how the simulated signals have almost identical spectrograms, but very different coherograms, consistent with the degree of correlation evident in the time domain traces shown in B. The coherogram also indicates the frequencies over which two signals are correlated. In this example, signals A and B are correlated at frequencies below approximately 20 Hz.
Image Not Available
Fig. 2.
Illustration of electroencephalogram channels, and coherence measurement. (A) Visual representation of channel locations and the two bipolar frontal channels, F7 and F8, which we used for coherence analysis. Areas in red are purely illustrative for the explanation of coherence. The bipolar frontal channels overlaying these regions may not record signals solely from the underlying cortex. (B) Simulated signals to illustrate interpretation of coherence. Signal “A” and signal “B” appear highly correlated in time, whereas signal “C” appears uncorrelated with both signals A and B. (CE) Spectrogram for simulated signals in B. The spectrogram plots signal power or energy as a function of time and frequency. Signals A, B, and C produce almost identical spectrograms; however, their coherograms will reflect differences in functional connectivity that may otherwise be overlooked. (F and G) The coherence indicates the correlation coefficient between two signals as a function of frequency (0 for no correlation, with a maximum value of 1 for perfect correlation). The coherogram plots the coherence as function of time, much like the spectrogram. This example shows how the simulated signals have almost identical spectrograms, but very different coherograms, consistent with the degree of correlation evident in the time domain traces shown in B. The coherogram also indicates the frequencies over which two signals are correlated. In this example, signals A and B are correlated at frequencies below approximately 20 Hz.
×
We computed group-level coherograms by taking the median across patients. We also calculated the coherence for the selected electroencephalogram epochs. The resulting coherence estimates were averaged for all epochs, and 95% CIs were computed via multitaper-based jackknife techniques.21,22  The coherence analysis parameters were as follows: window length T = 2 s with 0 s overlap, time-bandwidth product TW = 3, number of tapers K = 5, and spectral resolution of 2 W = 3 Hz. We estimated the peak coherence, and its frequency, of the frontal alpha oscillation for each individual subject. We then averaged across subjects to obtain the group-level peak coherence and frequency for these oscillations.
Statistical Analysis
To compare spectral and coherence estimates between groups, we used jackknife-based methods, the two-group test for spectra, and the two-group test for coherence, as implemented in the Chronux toolbox routine.22  This method accounts for the underlying spectral resolution of the spectral and coherence estimates and considers differences to be significant only if they are present for contiguous frequencies over a frequency band wider than the spectral resolution 2 W. Specifically, for frequencies f >2 W, the null hypothesis was rejected only if the test statistic exceeded the significance threshold over a contiguous frequency range ≥2 W. For frequencies 0 ≤ f ≤ 2 W, to account for the properties of multitaper spectral estimates at frequencies close to zero, the null hypothesis was rejected only if the test statistic exceeded the significance threshold over a contiguous frequency range from 0 to max (f,W) ≤ 2 W. We selected a significance threshold of P value less than 0.001 for comparisons between the two groups.
Results
Sevoflurane versus Propofol Power Spectra Analysis
We observed similarities and differences in the spectrograms of the sevoflurane and propofol general anesthesia groups (fig. 3, A–B). Both spectrograms were similarly characterized by large alpha band power. However, sevoflurane elicited higher power across the theta (4 to 8 Hz) and beta (12 to 25 Hz) frequency ranges (fig. 3, A–B). Sevoflurane general anesthesia electroencephalogram power exhibited an alpha oscillation peak (mean ± SD; peak frequency, 9.2 ± 0.84 Hz; peak power, 4.3 ± 3.5 dB) that was only slightly different from the propofol general anesthesia alpha oscillation peak (peak frequency, 10.3 ± 1.1 Hz; peak power, 2.1 ± 4.3 dB). We next compared the electroencephalogram spectrum between these two groups and found significant differences in power across most frequencies between 0.4 and 40 Hz. Sevoflurane exhibited increased electroencephalogram power across a range of frequencies except at slow oscillations (<0.4 Hz) and the propofol alpha oscillation peak (fig. 3C; 0.4 to 11.2 Hz, 14.7–40 Hz; P < 0.001, two-group test for spectra). As illustrated in figure 3C, compared with propofol-induced unconsciousness, sevoflurane-induced unconsciousness was characterized by larger theta and beta oscillation power, and similar slow and alpha oscillation power.
Fig. 3.
Group level spectral analysis comparing sevoflurane general anesthesia (GA) to propofol GA. (A) Group level spectrogram of sevoflurane GA (n = 30), showing increased power in slow, delta, theta, and alpha, beta frequency bands. (B) Group level spectrogram of propofol GA (n = 30), showing increased power in slow, delta, and alpha frequency bands. (C) Power spectra of sevoflurane GA versus propofol GA. Electroencephalogram power is significantly greater with sevoflurane GA over propofol GA across a broad frequency range spanning the alpha, delta, theta, and beta frequency bands (C: 0.4–11.2 Hz, 14.7–40 Hz; P < 0.001, two group test for spectra). Median spectra pre sented with 95% jackknife CIs. Horizontal solid black lines represent frequency ranges at which there was significant difference.
Image Not Available
Fig. 3.
Group level spectral analysis comparing sevoflurane general anesthesia (GA) to propofol GA. (A) Group level spectrogram of sevoflurane GA (n = 30), showing increased power in slow, delta, theta, and alpha, beta frequency bands. (B) Group level spectrogram of propofol GA (n = 30), showing increased power in slow, delta, and alpha frequency bands. (C) Power spectra of sevoflurane GA versus propofol GA. Electroencephalogram power is significantly greater with sevoflurane GA over propofol GA across a broad frequency range spanning the alpha, delta, theta, and beta frequency bands (C: 0.4–11.2 Hz, 14.7–40 Hz; P < 0.001, two group test for spectra). Median spectra pre sented with 95% jackknife CIs. Horizontal solid black lines represent frequency ranges at which there was significant difference.
×
Sevoflurane versus Propofol Coherence Analysis
We also observed similarities and differences in coherograms of the sevoflurane and propofol general anesthesia groups (fig. 4, A–B). Both coherograms were similarly characterized by alpha band coherence and the absence of slow oscillation coherence. However, the sevoflurane group coherogram also showed a coherence peak within the theta frequency range that was not evident in the propofol general anesthesia group (fig. 3, A–B; peak frequency, 4.9 ± 0.6 Hz; peak coherence, 0.58 ± 0.1). Sevoflurane general anesthesia electroencephalogram coherence exhibited an alpha oscillation peak (peak frequency, 9.8 ± 0.91 Hz; peak coherence, 0.73 ± 0.1) that was very similar to propofol general anesthesia alpha oscillation peak (peak frequency, 10.2 ± 1.3 Hz; peak coherence, 0.71 ± 0.1 dB). We next compared the electroencephalogram coherence between these two groups. We found that the sevoflurane and propofol coherence were qualitatively similar, showing a strong alpha peak, and lower slow oscillation peak. Sevoflurane exhibited increased electroencephalogram coherence across a range of theta and alpha frequencies (fig. 3C; 3.41 to 10.7 Hz; two-group test for coherence, P < 0.001), whereas propofol exhibited increased electroencephalogram coherence across a slightly different range of alpha and beta frequencies (fig. 3C; 11.7 to 19.5 Hz; two-group test for coherence, P < 0.001). As illustrated in figure 4C, sevoflurane and propofol general anesthesia were characterized by coherent frontal alpha oscillations with very similar peak frequencies and coherence values. However, sevoflurane also exhibited a coherent theta oscillation peak.
Fig. 4.
Group-level coherence analysis comparing sevoflurane general anesthesia (GA) to propofol GA. (A) Group level coherogram of sevoflurane GA (n = 30) showing coherence in the theta and alpha frequency bands. (B) Group level coherogram of propofol GA (n = 30), showing coherence in the alpha frequency band. (C) Coherence of sevoflurane GA versus propofol GA. Qualitatively, the alpha coherence between the two groups appeared similar. However, sevoflurane exhibited a theta coherence peak. Sevoflurane GA coherence across was higher than propofol GA at 3.41–10.7 Hz (two group test for coherence, P < 0.001). Propofol GA coherence across was higher than sevoflurane GA at 11.7–19.5 Hz (two group test for coherence, P < 0.001). Median coherence presented with 95% jackknife CIs. Horizontal solid black lines represent frequency ranges at which there was significant difference.
Image Not Available
Fig. 4.
Group-level coherence analysis comparing sevoflurane general anesthesia (GA) to propofol GA. (A) Group level coherogram of sevoflurane GA (n = 30) showing coherence in the theta and alpha frequency bands. (B) Group level coherogram of propofol GA (n = 30), showing coherence in the alpha frequency band. (C) Coherence of sevoflurane GA versus propofol GA. Qualitatively, the alpha coherence between the two groups appeared similar. However, sevoflurane exhibited a theta coherence peak. Sevoflurane GA coherence across was higher than propofol GA at 3.41–10.7 Hz (two group test for coherence, P < 0.001). Propofol GA coherence across was higher than sevoflurane GA at 11.7–19.5 Hz (two group test for coherence, P < 0.001). Median coherence presented with 95% jackknife CIs. Horizontal solid black lines represent frequency ranges at which there was significant difference.
×
Discussion
Sevoflurane- and propofol-induced electroencephalogram signatures appear grossly similar. However, our analysis identifies a distinct difference in theta coherence that may be further studied to provide insights into the neural circuit mechanisms of sevoflurane. We briefly summarize our findings as follows: (1) similar to propofol-induced frontal alpha oscillations, sevoflurane is characterized by coherent alpha oscillations with similar maximum power and coherence occurring at approximately 10 to 12 Hz; (2) also similar to propofol, sevoflurane is associated with slow oscillations at frequencies <1 Hz; (3) in contrast to propofol, sevoflurane is associated with increased power and coherence in the theta band.
These similarities in sevoflurane- and propofol-induced electroencephalogram dynamics are consistent with the notion that similar GABAergic neural circuit mechanisms are involved.2–5,14  This suggests that sevoflurane, like propofol, may also induce highly structured thalamocortical oscillations that interfere with cortical information processing, as well as slow oscillations that fragment cortical activity.7,9–12  Preliminary studies from our laboratory suggest that these electroencephalogram signatures are also representative of the ether derivatives, isoflurane and desflurane, suggesting that these oscillatory patterns may be used as electroencephalogram signatures of general anesthesia–induced loss of consciousness. It is important to note that intracortical mechanisms may also be necessary for the generation and propagation of coherent oscillations.23 
The coherent theta oscillations (approximately 5 Hz), characteristic of sevoflurane anesthesia, to our knowledge, have not been previously reported. Speculating on the possible significance of these theta oscillations, we note that pathological theta oscillations have been linked to dysfunction of low-threshold T-type calcium channels in thalamic neurons, leading to a thalamocortical dysrhythmia.23–26  Volatile anesthetics have been reported to modulate T-type calcium channels at clinically relevant concentrations in the dorsal root ganglia, hippocampal, and thalamic relay neurons.27–31  These parallels lead us to hypothesize that sevoflurane-induced theta oscillations may be indicative of profound thalamic deafferentation. If true, this electroencephalogram signature along with those of slow and alpha oscillations may be useful to monitor depth of anesthesia in real time. In the future, it would be important to study the spatio-temporal dynamics of this oscillatory dynamic with respect to depth of anesthesia.
Our findings suggest that propofol and sevoflurane, despite quantitative differences in the electroencephalogram power spectrum, exhibit highly coherent frontal alpha oscillations that have been associated with entrainment of thalamocortical communications. However, sevoflurane also exhibits a theta-band coherence which was not present under propofol. Coherent theta oscillations are not generally present in the awake eyes closed state,7,9  leading us to conclude that this coherence signature is induced by sevoflurane. Also, we were able to observe these similarities and differences in electroencephalogram spectra and coherences in data recorded during routine care of patients undergoing a variety of surgical procedures, and under different coadministered medications, suggesting that these effects are robust.
The electroencephalogram recordings analyzed in this article were obtained from frontal channels; as a result, our analysis was unable to examine anterior-posterior connectivity32  that have been reported as other cortical dynamics underlying anesthesia-induced unconsciousness. Because this study was performed in the clinical setting with concomitant administration of opioids, we were unable to perform detailed characterizations of changing behavior and consciousness during controlled induction and emergence, limiting our inferences to a clinically unconscious state. Future studies using high-density electroencephalogram and behavioral tasks will allow us to analyze connectivity and phase-amplitude coupling under sevoflurane and other inhaled anesthetics and their relation to varying degrees of consciousness.
In summary, the current analysis suggests a potential shared GABAergic mechanism for propofol and sevoflurane at clinically relevant doses. Furthermore, it details electroencephalogram signatures that can be used to identify and monitor the shared and differential effects of anesthetic agents, providing a foundation for future analyses.
Acknowledgments
Supported by grant numbers DP2-OD006454 (to Dr. Purdon), DP1-OD003646 and TR01-GM104948 (to Dr. Brown), and T32GM007592 (to Dr. Akeju) from the National Institutes of Health, Bethesda, Maryland; Foundation of Anesthesia Education and Research, Rochester, Minnesota (to Dr. Akeju); Massachusetts General Hospital Faculty Development Award, Boston, Massachusetts (to Dr. Akeju); and funds from the Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Competing Interests
Drs. Akeju, Brown, and Purdon have submitted a provisional patent application describing the use of the electroencephalogram measures described in this article for monitoring sedation and general anesthesia. The other authors declare no competing interests.
References
Eger, EIII New inhaled anesthetics.. Anesthesiology. (1994). 80 906–22 [Article] [PubMed]
Campagna, JA, Miller, KW, Forman, SA Mechanisms of actions of inhaled anesthetics.. N Engl J Med. (2003). 348 2110–24 [Article] [PubMed]
Alkire, MT, Hudetz, AG, Tononi, G Consciousness and anesthesia.. Science. (2008). 322 876–80 [Article] [PubMed]
Franks, NP General anaesthesia: From molecular targets to neuronal pathways of sleep and arousal.. Nat Rev Neurosci. (2008). 9 370–86 [Article] [PubMed]
Rudolph, U, Antkowiak, B Molecular and neuronal substrates for general anaesthetics.. Nat Rev Neurosci. (2004). 5 709–20 [Article] [PubMed]
Vijayan, S, Ching, S, Purdon, PL, Brown, EN, Kopell, NJ Thalamocortical mechanisms for the anteriorization of α rhythms during propofol-induced unconsciousness.. J Neurosci. (2013). 33 11070–5 [Article] [PubMed]
Purdon, PL, Pierce, ET, Mukamel, EA, Prerau, MJ, Walsh, JL, Wong, KF, Salazar-Gomez, AF, Harrell, PG, Sampson, AL, Cimenser, A, Ching, S, Kopell, NJ, Tavares-Stoeckel, C, Habeeb, K, Merhar, R, Brown, EN Electroencephalogram signatures of loss and recovery of consciousness from propofol.. Proc Natl Acad Sci U S A. (2013). 110 E1142–51 [Article] [PubMed]
Chen, Z, Purdon, PL, Harrell, G, Pierce, ET, Walsh, J, Brown, EN, Barbieri, R Dynamic assessment of baroreflex control of heart rate during induction of propofol anesthesia using a point process method.. Ann Biomed Eng. (2011). 39 260–76 [Article] [PubMed]
Cimenser, A, Purdon, PL, Pierce, ET, Walsh, JL, Salazar-Gomez, AF, Harrell, PG, Tavares-Stoeckel, C, Habeeb, K, Brown, EN Tracking brain states under general anesthesia by using global coherence analysis.. Proc Natl Acad Sci U S A. (2011). 108 8832–7 [Article] [PubMed]
Murphy, M, Bruno, MA, Riedner, BA, Boveroux, P, Noirhomme, Q, Landsness, EC, Brichant, JF, Phillips, C, Massimini, M, Laureys, S, Tononi, G, Boly, M Propofol anesthesia and sleep: A high-density EEG study.. Sleep. (2011). 34 283–91A [PubMed]
Supp, GG, Siegel, M, Hipp, JF, Engel, AK Cortical hypersynchrony predicts breakdown of sensory processing during loss of consciousness.. Curr Biol. (2011). 21 1988–93 [Article] [PubMed]
Ching, S, Cimenser, A, Purdon, PL, Brown, EN, Kopell, NJ Thalamocortical model for a propofol-induced alpha-rhythm associated with loss of consciousness.. Proc Natl Acad Sci U S A. (2010). 107 22665–70 [Article] [PubMed]
Brown, EN, Lydic, R, Schiff, ND General anesthesia, sleep, and coma.. N Engl J Med. (2010). 363 2638–50 [Article] [PubMed]
Brown, EN, Purdon, PL, Van Dort, CJ General anesthesia and altered states of arousal: A systems neuroscience analysis.. Annu Rev Neurosci. (2011). 34 601–28 [Article] [PubMed]
Lewis, LD, Weiner, VS, Mukamel, EA, Donoghue, JA, Eskandar, EN, Madsen, JR, Anderson, WS, Hochberg, LR, Cash, SS, Brown, EN, Purdon, PL Rapid fragmentation of neuronal networks at the onset of propofol-induced unconsciousness.. Proc Natl Acad Sci U S A. (2012). 109 E3377–86 [Article] [PubMed]
Feshchenko, VA, Veselis, RA, Reinsel, RA Propofol-induced alpha rhythm.. Neuropsychobiology. (2004). 50 257–66 [Article] [PubMed]
Gugino, LD, Chabot, RJ, Prichep, LS, John, ER, Formanek, V, Aglio, LS Quantitative EEG changes associated with loss and return of consciousness in healthy adult volunteers anaesthetized with propofol or sevoflurane.. Br J Anaesth. (2001). 87 421–8 [Article] [PubMed]
Li, D, Voss, LJ, Sleigh, JW, Li, X Effects of volatile anesthetic agents on cerebral cortical synchronization in sheep.. Anesthesiology. (2013). 119 81–8 [Article] [PubMed]
Kreuzer, M, Hentschke, H, Antkowiak, B, Schwarz, C, Kochs, EF, Schneider, G Cross-approximate entropy of cortical local field potentials quantifies effects of anesthesia—A pilot study in rats.. BMC Neurosci. (2010). 11 122 [Article] [PubMed]
Voss, LJ, Ludbrook, G, Grant, C, Sleigh, JW, Barnard, JP Cerebral cortical effects of desflurane in sheep: Comparison with isoflurane, sevoflurane and enflurane.. Acta Anaesthesiol Scand. (2006). 50 313–9 [Article] [PubMed]
Percival, DB, Walden, AT Spectral Analysis for Physical Applications: Multitaper and Conventional Univariate Techniques. (1993). Cambridge; New York Cambridge University Press
Bokil, H, Purpura, K, Schoffelen, JM, Thomson, D, Mitra, P Comparing spectra and coherences for groups of unequal size.. J Neurosci Methods. (2007). 159 337–45 [Article] [PubMed]
Williams, ST, Conte, MM, Goldfine, AM, Noirhomme, Q, Gosseries, O, Thonnard, M, Beattie, B, Hersh, J, Katz, DI, Victor, JD, Laureys, S, Schiff, ND Common resting brain dynamics indicate a possible mechanism underlying zolpidem response in severe brain injury.. Elife. (2013). 2 e01157 [PubMed]
Jeanmonod, D, Magnin, M, Morel, A Low-threshold calcium spike bursts in the human thalamus. Common physiopathology for sensory, motor and limbic positive symptoms.. Brain. (1996). 119 (Pt 2) 363–75 [Article] [PubMed]
Llinás, RR, Ribary, U, Jeanmonod, D, Kronberg, E, Mitra, PP Thalamocortical dysrhythmia: A neurological and neuropsychiatric syndrome characterized by magnetoencephalography.. Proc Natl Acad Sci U S A. (1999). 96 15222–7 [Article] [PubMed]
Llinás, R, Urbano, FJ, Leznik, E, Ramírez, RR, van Marle, HJ Rhythmic and dysrhythmic thalamocortical dynamics: GABA systems and the edge effect.. Trends Neurosci. (2005). 28 325–33 [Article] [PubMed]
McDowell, TS, Pancrazio, JJ, Barrett, PQ, Lynch, CIII Volatile anesthetic sensitivity of T-type calcium currents in various cell types.. Anesth Analg. (1999). 88 168–73 [PubMed]
Nader, R, Forghani, R, Krnjević, K In rat hippocampal slices, NMDA receptor-mediated EPSPs are more sensitive to hypoxia than AMPA receptor-mediated EPSPs.. Neurosci Lett. (1998). 245 135–8 [Article] [PubMed]
Ries, CR, Puil, E Mechanism of anesthesia revealed by shunting actions of isoflurane on thalamocortical neurons.. J Neurophysiol. (1999). 81 1795–801 [PubMed]
Study, RE Isoflurane inhibits multiple voltage-gated calcium currents in hippocampal pyramidal neurons.. Anesthesiology. (1994). 81 104–16 [Article] [PubMed]
Todorovic, SM, Lingle, CJ Pharmacological properties of T-type Ca2+ current in adult rat sensory neurons: Effects of anticonvulsant and anesthetic agents.. J Neurophysiol. (1998). 79 240–52 [PubMed]
Lee, U, Ku, S, Noh, G, Baek, S, Choi, B, Mashour, GA Disruption of frontal-parietal communication by ketamine, propofol, and sevoflurane.. Anesthesiology. (2013). 118 1264–75 [Article] [PubMed]
Fig. 1.
Representative individual spectrogram and the time domain electroencephalogram data obtained during sevoflurane general anesthesia (GA), and propofol GA. (A) Spectrogram of a patient who received sevoflurane GA. (B) Spectrogram of a patient who received propofol GA. The spectrogram displays the frequency content of signals as they change over time. Frequency is plotted on the y-axis, time is plotted on the x-axis, and the energy or power in the signal is indicated in color. Both spectrograms show power in the slow and alpha frequency bands. However, sevoflurane GA is further characterized by increased power in the theta and beta frequency bands. (C) Representative 10-s electroencephalogram traces of sevoflurane GA. (D) Representative 10-s electroencephalogram traces of propofol GA illustrating the gross similarities in electroencephalogram signal amplitudes in C. (EL) Bandpass-filtered electroencephalogram signals from the raw tracings to more clearly illustrate gross similarities in the electroencephalogram.
Image Not Available
Fig. 1.
Representative individual spectrogram and the time domain electroencephalogram data obtained during sevoflurane general anesthesia (GA), and propofol GA. (A) Spectrogram of a patient who received sevoflurane GA. (B) Spectrogram of a patient who received propofol GA. The spectrogram displays the frequency content of signals as they change over time. Frequency is plotted on the y-axis, time is plotted on the x-axis, and the energy or power in the signal is indicated in color. Both spectrograms show power in the slow and alpha frequency bands. However, sevoflurane GA is further characterized by increased power in the theta and beta frequency bands. (C) Representative 10-s electroencephalogram traces of sevoflurane GA. (D) Representative 10-s electroencephalogram traces of propofol GA illustrating the gross similarities in electroencephalogram signal amplitudes in C. (EL) Bandpass-filtered electroencephalogram signals from the raw tracings to more clearly illustrate gross similarities in the electroencephalogram.
×
Fig. 2.
Illustration of electroencephalogram channels, and coherence measurement. (A) Visual representation of channel locations and the two bipolar frontal channels, F7 and F8, which we used for coherence analysis. Areas in red are purely illustrative for the explanation of coherence. The bipolar frontal channels overlaying these regions may not record signals solely from the underlying cortex. (B) Simulated signals to illustrate interpretation of coherence. Signal “A” and signal “B” appear highly correlated in time, whereas signal “C” appears uncorrelated with both signals A and B. (CE) Spectrogram for simulated signals in B. The spectrogram plots signal power or energy as a function of time and frequency. Signals A, B, and C produce almost identical spectrograms; however, their coherograms will reflect differences in functional connectivity that may otherwise be overlooked. (F and G) The coherence indicates the correlation coefficient between two signals as a function of frequency (0 for no correlation, with a maximum value of 1 for perfect correlation). The coherogram plots the coherence as function of time, much like the spectrogram. This example shows how the simulated signals have almost identical spectrograms, but very different coherograms, consistent with the degree of correlation evident in the time domain traces shown in B. The coherogram also indicates the frequencies over which two signals are correlated. In this example, signals A and B are correlated at frequencies below approximately 20 Hz.
Image Not Available
Fig. 2.
Illustration of electroencephalogram channels, and coherence measurement. (A) Visual representation of channel locations and the two bipolar frontal channels, F7 and F8, which we used for coherence analysis. Areas in red are purely illustrative for the explanation of coherence. The bipolar frontal channels overlaying these regions may not record signals solely from the underlying cortex. (B) Simulated signals to illustrate interpretation of coherence. Signal “A” and signal “B” appear highly correlated in time, whereas signal “C” appears uncorrelated with both signals A and B. (CE) Spectrogram for simulated signals in B. The spectrogram plots signal power or energy as a function of time and frequency. Signals A, B, and C produce almost identical spectrograms; however, their coherograms will reflect differences in functional connectivity that may otherwise be overlooked. (F and G) The coherence indicates the correlation coefficient between two signals as a function of frequency (0 for no correlation, with a maximum value of 1 for perfect correlation). The coherogram plots the coherence as function of time, much like the spectrogram. This example shows how the simulated signals have almost identical spectrograms, but very different coherograms, consistent with the degree of correlation evident in the time domain traces shown in B. The coherogram also indicates the frequencies over which two signals are correlated. In this example, signals A and B are correlated at frequencies below approximately 20 Hz.
×
Fig. 3.
Group level spectral analysis comparing sevoflurane general anesthesia (GA) to propofol GA. (A) Group level spectrogram of sevoflurane GA (n = 30), showing increased power in slow, delta, theta, and alpha, beta frequency bands. (B) Group level spectrogram of propofol GA (n = 30), showing increased power in slow, delta, and alpha frequency bands. (C) Power spectra of sevoflurane GA versus propofol GA. Electroencephalogram power is significantly greater with sevoflurane GA over propofol GA across a broad frequency range spanning the alpha, delta, theta, and beta frequency bands (C: 0.4–11.2 Hz, 14.7–40 Hz; P < 0.001, two group test for spectra). Median spectra pre sented with 95% jackknife CIs. Horizontal solid black lines represent frequency ranges at which there was significant difference.
Image Not Available
Fig. 3.
Group level spectral analysis comparing sevoflurane general anesthesia (GA) to propofol GA. (A) Group level spectrogram of sevoflurane GA (n = 30), showing increased power in slow, delta, theta, and alpha, beta frequency bands. (B) Group level spectrogram of propofol GA (n = 30), showing increased power in slow, delta, and alpha frequency bands. (C) Power spectra of sevoflurane GA versus propofol GA. Electroencephalogram power is significantly greater with sevoflurane GA over propofol GA across a broad frequency range spanning the alpha, delta, theta, and beta frequency bands (C: 0.4–11.2 Hz, 14.7–40 Hz; P < 0.001, two group test for spectra). Median spectra pre sented with 95% jackknife CIs. Horizontal solid black lines represent frequency ranges at which there was significant difference.
×
Fig. 4.
Group-level coherence analysis comparing sevoflurane general anesthesia (GA) to propofol GA. (A) Group level coherogram of sevoflurane GA (n = 30) showing coherence in the theta and alpha frequency bands. (B) Group level coherogram of propofol GA (n = 30), showing coherence in the alpha frequency band. (C) Coherence of sevoflurane GA versus propofol GA. Qualitatively, the alpha coherence between the two groups appeared similar. However, sevoflurane exhibited a theta coherence peak. Sevoflurane GA coherence across was higher than propofol GA at 3.41–10.7 Hz (two group test for coherence, P < 0.001). Propofol GA coherence across was higher than sevoflurane GA at 11.7–19.5 Hz (two group test for coherence, P < 0.001). Median coherence presented with 95% jackknife CIs. Horizontal solid black lines represent frequency ranges at which there was significant difference.
Image Not Available
Fig. 4.
Group-level coherence analysis comparing sevoflurane general anesthesia (GA) to propofol GA. (A) Group level coherogram of sevoflurane GA (n = 30) showing coherence in the theta and alpha frequency bands. (B) Group level coherogram of propofol GA (n = 30), showing coherence in the alpha frequency band. (C) Coherence of sevoflurane GA versus propofol GA. Qualitatively, the alpha coherence between the two groups appeared similar. However, sevoflurane exhibited a theta coherence peak. Sevoflurane GA coherence across was higher than propofol GA at 3.41–10.7 Hz (two group test for coherence, P < 0.001). Propofol GA coherence across was higher than sevoflurane GA at 11.7–19.5 Hz (two group test for coherence, P < 0.001). Median coherence presented with 95% jackknife CIs. Horizontal solid black lines represent frequency ranges at which there was significant difference.
×
Table 1.
Characteristics of Patients Studied
Characteristics of Patients Studied×
Image Not Available
Table 1.
Characteristics of Patients Studied
Characteristics of Patients Studied×
×
Table 2.
General Anesthesia Induction and Maintenance Agents
General Anesthesia Induction and Maintenance Agents×
Image Not Available
Table 2.
General Anesthesia Induction and Maintenance Agents
General Anesthesia Induction and Maintenance Agents×
×
Table 3.
Adjunct Medications Administered*
Adjunct Medications Administered*×
Image Not Available
Table 3.
Adjunct Medications Administered*
Adjunct Medications Administered*×
×